Skip to main content
. 2015 Feb 15;15:151. doi: 10.1186/s12889-015-1476-0

Table 5.

Participants in, and focus of, studies

Type of participants Number of studies Focus Source
General populations 46 HBV [48-51,55,56,58,59,63,66,67,69-75,78-84,86-93,95,97,98]
HCV [61,65]
HBV & HCV [53,62,76]
HBV & liver cancer [54,57,77,96]
Blood-borne viral infections [64]
People with chronic HBV 2 HBV [94,97]
Injecting drug users with HCV 1 HCV [59]
General population and people with HBV 1 HBV [52]